Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Prescriptions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 72 Radiotherapy 41 pembrolizumab 36 Cetuximab 34 Paclitaxel 32 Carboplatin 32 Docetaxel 28 Radiotherapy, Intensity-Modulated 22 Fluorouracil 22 Nivolumab 15 Drug Therapy 14 Radiation 12 cemiplimab 8 Erlotinib Hydrochloride 8 Blood Specimen Collection 8 130-nm albumin-bound paclitaxel 8 durvalumab 7 atezolizumab 6 Surveys and Questionnaires 6 Panitumumab 6 Esophagectomy 6 Afatinib 6 Surgical Procedures, Operative 5 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Gemcitabine 5 Cyclophosphamide 5 Chemoradiotherapy 5 Capecitabine 5 Albumin-Bound Paclitaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02442375 2025-11-18

UPGRADE-RT

Radboud University Medical Center

Phase 3 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡